Brief: Soligenix Inc - Positive Outcome In 75% Of Ctcl Patients Treated With Hybryte For 18 Weeks
14/04/2025 12:33
April 14 (Reuters) - Soligenix Inc SNGX.O: SOLIGENIX INC - POSITIVE OUTCOME IN 75% OF CTCL PATIENTS TREATED WITH HYBRYTE FOR 18 WEEKS SOLIGENIX INC - HYBRYTE APPEARS TO BE SAFE AND WELL TOLERATED IN ALL PATIENTS Source text: ID:nPn17TqZja Further company coverage: SNGX.O ((Reuters.Briefs@thomsonreuters.com;))